Healthcare Market Research Reports & Industry Analysis
MarketResearch.com provides detailed reports for various countries around the world and the healthcare needs and offerings in those countries. These reports also profile the types of administrations and regulations and policies that are in place in various regions and segments in each country.
Reports are available in industry sub-categories such as: wellness and preventative programming, sports medicine, insurance and managed care, and clinical guidelines and best practices. Readers may also find data regarding alternative and complementary medicine, nursing, public health and information technology. Though not always considered when first thinking of healthcare, information may also be found on veterinary health.
Reviews of various equipment and pharmaceuticals in specific regions are made available regarding multiple countries. Herbal and traditional products are contrasted and compared, and global access to sufficient ambulance services is discussed.
Healthcare Industry Research & Market Reports
-
Global Drug of Abuse Testing Market (By Product Type, Sample/Test Type, End Users / Setting Type, Region), Regulatory Status, 20 Company Profile – Forecast to 2024
... projected to cross US$ 5 Billion by 2024. Drugs of abuse testing involves detection of one or more illegal and/or prescribed substances in the urine, blood, saliva, hair, or sweat. The use of illicit drugs ... Read More
-
Sub-Saharan Africa Pharmaceuticals & Healthcare Q4 2018
... within the generic medicines sector, while the larger, moredeveloped markets present viable opportunities for patented medicine sales in urban regions. Cooperative agreements withinternational firms will provide opportunities for domestic firms to expand their manufacturing capacities. Read More
-
Hong Kong Pharmaceuticals & Healthcare Q4 2018
... cope with a rapidly ageing population. On the private side too, the government has beenpromoting the development of private hospitals as part of its reform initiatives to improve the long-term sustainability of thecountry’s healthcare system. Read More
-
Ghana Pharmaceuticals & Healthcare Q4 2018
... has led to difficulties doingbusiness, including high operational costs for foreign companies. While Ghana is positioned as one of the more attractivepharmaceutical markets for multinational firms on a regional basis, generic products will maintain a ... Read More
-
Europe Pharmaceuticals & Healthcare Q4 2018
... to region-specific trends. Themore developed Western markets will continue to be favoured by innovative drugmakers due to stronger regulatory oversight andgreater purchasing power, although growth in these markets will be suppressed by aggressive cost-containment. Revenue ... Read More
-
Latin America Pharmaceuticals & Healthcare Q4 2018
... for multinational pharmaceutical firms with a risingburden of chronic diseases and increasing access to healthcare services. However, in the short-term growth opportunities in theregion's major markets will be repressed by significant political and economic risks. Read More
-
Middle East And North Africa Pharmaceuticals & Healthcare Q4 2018
... opportunities for multinational drugmakers looking to expand to emergingmarkets. Heightened industry and country risk dissuade company interest and the larger markets dominate multinational activityfor patented medicine sales. Ample opportunities exist in the generics market segment. Read More
-
Costa Rica Pharmaceuticals & Healthcare Q4 2018
... offers superior market access and development opportunities to multinationals based on factorssuch as continuous improvement in healthcare infrastructure and government commitment to upholding an attractive businessenvironment. Additionally, the demand for innovative medicines will still need ... Read More
-
El Salvador Pharmaceuticals & Healthcare Q4 2018
... for pharmaceutical investment. Despite this, a steady number ofcollaborations with international organisations and businesses is improving the standard of healthcare and raising the long-termgrowth prospects of the country's low penetration of pharmaceuticals and medical equipment. Read More
-
Asia Pharmaceuticals & Healthcare Q4 2018
... However, these markets will no longer providesignificant revenue growth due to aggressive cost-containment. Instead, growth opportunities will be plentiful in emerging markets.We note that due to continued regulatory challenges and a growing focus on cost-efficiency, ... Read More
-
Global Pharmaceuticals & Healthcare Q4 2018
... face increasingly protectionist policies in emerging markets.These policies can be divided into localisation requirements and investment incentives, including subsidies and tariffs.Multinational pharmaceutical firms must assess their market entry strategy to reflect each market's individual protectioniststance. Read More
-
Germany Pharmaceuticals & Healthcare Q4 2018
... to services, will continue tosupport this potential. However, we do caution that market access is now challenging, as authorities use a range of cost-containment measures and downward price pressures as a means of controlling state ... Read More
-
Nicaragua Pharmaceuticals & Healthcare Q4 2018
... pharmaceutical companies operating in thecountry. Furthermore, the ongoing political crisis and heightened social unrest will exacerbate the risks associated with Nicaragua,further deterring multinational drugmakers from investing in what is already one of the least attractive ... Read More
-
Uganda Pharmaceuticals & Healthcare Q4 2018
... remain dominant, while the government plans to localisedrug production to boost medicine sustainability. While the market has brighter long-term prospects, multinational drugmakerappetite will remain subdued despite the positive economic growth forecast over the coming years. Read More
-
Mental Health & Substance Abuse Services
... include Acadia Healthcare, Hazelden Betty Ford Foundation, and Spectrum Health Systems (all based in the US), along with the Centre for Addiction and Mental Health (Canada), and the Crossroads Centre (Antigua). COMPETITIVE LANDSCAPE Demand for ... Read More
-
Health Insurance Carriers
... and UnitedHealth Group (all based in the US), as well as AEGON (the Netherlands), Allianz (Germany), and BUPA (UK). COMPETITIVE LANDSCAPE Demand for health insurance products is driven by cost of medical care. The profitability ... Read More
-
Global Drug of Abuse Testing Market (By Product Type, Sample/Test Type, End Users / Setting Type, Region), Regulatory Status, 20 Company Profile – Forecast to 2024
... projected to cross US$ 5 Billion by 2024. Drugs of abuse testing involves detection of one or more illegal and/or prescribed substances in the urine, blood, saliva, hair, or sweat. The use of illicit drugs ... Read More
-
SCIO Health Analytics - Strategic SWOT Analysis Review
... key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope ... Read More
-
Catholic Medical Center - Strategic SWOT Analysis Review
... key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope ... Read More
-
Panama Pharmaceuticals & Healthcare Q4 2018
... system inefficiencies will continueto weigh on the country’s ability to improve access to healthcare. Sustained pro-growth economic policies and the Panama Canalwill continue to support the country’s position as a logistic and export hub, including ... Read More
-
Poland Pharmaceuticals & Healthcare Q4 2018
... future of the Fund; however, the outlook for the pharmaceutical market andhealthcare sector remain positive. Continued state healthcare funding growth and consumer-led economic growth will provide aboost to market expenditure, maintaining the country's regional outperformance. Read More
-
Azerbaijan Pharmaceuticals & Healthcare Q4 2018
... pharmaceutical market, we remain cautious about its commercial attractiveness to multinationals, at least in theshort term. The over-reliance on out-of-pocket payments has made the market vulnerable to economic fluctuations, especiallygiven its reliance on imported medicines. Read More
-
Companion Animal Diagnostics Market in US - Industry Outlook and Forecast 2018-2023
... approximately 7% during 2017-2023. The consumers are signing up for regular diagnosis and glucose monitoring that help them identify the disease at an early stage and begin appropriate therapy to reduce the risk of diabetic ... Read More
-
Namibia Pharmaceuticals & Healthcare Q4 2018
... and efficiency issues within the public healthcare sector. The small middle-and upper-class segments provide pockets of demand for innovative medicines, which will continue to be imported by key regionalplayers and representative offices of established multinationals. Read More
-
Zimbabwe Pharmaceuticals & Healthcare Q4 2018
... multinational drugmakers are deterred by thechallenging macroeconomic environment. Achieving self-sufficiency in the sector will require currency regime reform; however, itremains unclear which new regime they will adopt. This creates uncertain conditions in Zimbabwe's pharmaceutical market ... Read More
